KSCM
BLUE

Kamunting Street Capital Management’s bluebird bio BLUE Stock Holding History

Kamunting Street Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,750
Closed -$145K – 36
2022
Q2 		$145K Buy
+1,750
New +$136K 0.2% 31

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kamunting Street Capital Management's BLUE Position: Q3 2022 in Review

Kamunting Street Capital Management sold out of bluebird bio (BLUE) in Q3 2022, closing a stake of 1,750 shares — an estimated $145K sold.

Kamunting Street Capital Management first reported a position in BLUE in Q2 2022 and held it in 1 quarter. The position peaked at $145K in Q2 2022. 162 funds tracked by Wall St. Rank hold BLUE as of Q3 2022.

  • Kamunting Street Capital Management reported no remaining bluebird bio position as of Q3 2022 after selling out during the quarter.
  • Kamunting Street Capital Management sold 1,750 bluebird bio shares in Q3 2022, an estimated $145K.
  • Kamunting Street Capital Management first reported a position in bluebird bio in Q2 2022 and held it in 1 quarter.
  • Kamunting Street Capital Management's bluebird bio position peaked at $145K in Q2 2022.
  • 162 funds tracked by Wall St. Rank held bluebird bio as of Q3 2022.

Based on Kamunting Street Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.